Robert G. Lerner, M.D.
In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.
This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.
Release Date: 09/28/2002
Upon completion of this Cyberounds®, you should be able to:
Describe the term "thrombophilia" and list the recently discovered thrombophilic mutations such as Factor V Leiden, Prothrombin G20210A and MTHFR
Discuss the increased risk of thrombosis for pregnant women with thrombophilia, and the risk of pregnancy loss and complications
Discuss the preliminary data supportive of enoxaparin to prevent pregnancy loss.
